These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Venous stenosis and occlusion in the presence of endocardial leads in patients referred for transvenous lead extraction. Boczar K; Zabek A; Haberka K; Debski M; Rydlewska A; Musial R; Lelakowski J; Malecka B Acta Cardiol; 2017 Feb; 72(1):61-67. PubMed ID: 28597736 [TBL] [Abstract][Full Text] [Related]
47. [Quality of life in patients after anti-arrhythmic devices implantation]. Lełakowska-Piela M; Pudło J; Rydlewska A; Senderek T; Lelakowski J Pol Merkur Lekarski; 2013 Dec; 35(210):331-8. PubMed ID: 24490461 [TBL] [Abstract][Full Text] [Related]
48. Transvenous lead extraction in patients with cardiac resynchronization therapy devices is not associated with increased 30-day mortality. Gould J; Klis M; Porter B; Sieniewicz BJ; Sidhu BS; Claridge S; Williams SE; Shetty A; O'Neill M; Gill J; Rinaldi CA Europace; 2019 Jun; 21(6):928-936. PubMed ID: 30590509 [TBL] [Abstract][Full Text] [Related]
49. Candidacy for a Subcutaneous Implantable Cardioverter Defibrillator in Patients with Cardiac Resynchronization Therapy. Kawabata M; Goya M; Takahashi Y; Maeda S; Yagishita A; Shirai Y; Kaneko M; Shiohira S; Hirao K Int Heart J; 2018 Sep; 59(5):951-958. PubMed ID: 30101850 [TBL] [Abstract][Full Text] [Related]
50. Venous Stenosis and Occlusion in the Presence of Endocardial Leads. Boczar K; Ząbek A; Haberka K; Hardzina M; Dębski M; Rydlewska A; Nowosielska-Ząbek E; Lelakowski J; Małecka B Adv Clin Exp Med; 2016; 25(1):83-91. PubMed ID: 26935502 [TBL] [Abstract][Full Text] [Related]
51. Transvenous Lead Extraction in Chronic Kidney Disease and Dialysis Patients With Infected Cardiac Devices. Barakat AF; Wazni OM; Tarakji KG; Callahan T; Nimri N; Saliba WI; Shah S; Abdur Rehman K; Rickard J; Brunner MP; Martin DO; Kanj M; Baranowski B; Cantillon D; Niebauer M; Dresing T; Lindsay BD; Wilkoff BL; Hussein AA Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005706. PubMed ID: 29321192 [TBL] [Abstract][Full Text] [Related]
52. Prevention of venous thrombosis by warfarin after permanent transvenous leads implantation in high-risk patients. Costa R; Da Silva KR; Rached R; Martinelli Filho M; Carnevale FC; Moreira LF; Stolf NA Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S247-51. PubMed ID: 19250106 [TBL] [Abstract][Full Text] [Related]
53. Transvenous Lead Extraction during Cardiac Implantable Device Upgrade: Results from the Multicenter Swiss Lead Extraction Registry. Haeberlin A; Noti F; Breitenstein A; Auricchio A; Reichlin T; Conte G; Klersy C; Curti M; Pruvot E; Domenichini G; Schaer B; Kühne M; Gruszczynski M; Burri H; Kobza R; Grebmer C; Regoli FD J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629216 [TBL] [Abstract][Full Text] [Related]
54. Intra-pocket ultrasound-guided axillary vein puncture vs. cephalic vein cutdown for cardiac electronic device implantation: the ACCESS trial. Charles P; Ditac G; Montoy M; Thenard T; Courand PY; Lantelme P; Harbaoui B; Fareh S Eur Heart J; 2023 Dec; 44(46):4847-4858. PubMed ID: 37832512 [TBL] [Abstract][Full Text] [Related]
55. Predictors of fluoroscopy time and procedural failure during biventricular device implantation. Hsu JC; Badhwar N; Lee BK; Vedantham V; Tseng ZH; Marcus GM Am J Cardiol; 2012 Jul; 110(2):240-5. PubMed ID: 22483384 [TBL] [Abstract][Full Text] [Related]
56. Clinical significance of collateral superficial vein across clavicle in patients with cardiovascular implantable electronic device. Hosoda J; Ishikawa T; Matsushita K; Matsumoto K; Sugano T; Ishigami T; Kimura K; Umemura S Circ J; 2014; 78(8):1846-50. PubMed ID: 24848952 [TBL] [Abstract][Full Text] [Related]
57. Impact of transvenous cardiac implantable electronic devices in chronic hemodialysis patients: a single-center, observational comparative study. Jeong S; Nam GB; Chang JW; Kim MJ; Han Y; Kwon TW; Cho YP BMC Nephrol; 2018 Oct; 19(1):281. PubMed ID: 30342493 [TBL] [Abstract][Full Text] [Related]
58. Unscheduled Emergency Visits after Cardiac Devices Implantation: Comparison between Cardioverter Defibrillators and Cardiac Resynchronization Therapy Devices in less than one year of Follow Up. Warpechowski Neto S; Ley LLG; Almeida ED; Saffi MAL; Dutra LZ; Ley ALG; Sant'Anna RT; Lima GG; Kalil RAK; Leiria TLL Arq Bras Cardiol; 2019 May; 112(5):491-498. PubMed ID: 30810607 [TBL] [Abstract][Full Text] [Related]
59. Safety and Effectiveness of Transvenous Lead Extraction in Patients with Infected Cardiac Resynchronization Therapy Devices; Is It More Risky than Extraction of Other Systems? Stefańczyk P; Nowosielecka D; Polewczyk A; Tułecki Ł; Tomków K; Jacheć W; Lewicka E; Tomaszewski A; Kutarski A Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627340 [TBL] [Abstract][Full Text] [Related]
60. Cardiac implantable electronic devices in patients with persistent left superior vena cava-A single center experience. Ghazzal B; Sabayon D; Kiani S; Leon AR; Delurgio D; Patel AM; Lloyd MS; Westerman S; Shah A; Merchant FM; El-Chami MF J Cardiovasc Electrophysiol; 2020 May; 31(5):1175-1181. PubMed ID: 32237003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]